|
Trade Wars
China’s Manufacturing Is Booming Despite Trump’s Tariffs
Chinese industrial production broke records this year as its factories churned out more cars, machinery and chemicals than ever before. Despite the disruptions of tariffs, the country’s trade surplus in goods has set a record, as growing shipments to Asia, Europe, Latin America and Africa offset the hit from Trump’s levies on direct sales to the U.S. Chinese companies that built their business around low trade barriers to sell into the U.S. have adapted and in some cases are bouncing back.
The Chinese manufacturing juggernaut shows little sign of slowing. China reported a goods trade surplus of more than $1 trillion for the year through November, while manufacturing output in the first 10 months of the year was up 7% compared with the same period in 2024. Strip out imports of energy, food and raw materials, and China is on track this year to post a surplus in manufactured goods of around $2 trillion, a huge sum that is on a par with the annual national income of Russia or Italy. China’s surprisingly strong export performance hasn’t been without costs. The economy is battling an insidious phenomenon dubbed “involution,” in which cutthroat competition and ballooning industrial capacity are pushing down prices, profits and incomes.
Read more at the WSJ
PepsiCo Planning Price Cuts Amid Affordability Crunch
PepsiCo, the maker of Lay’s, Doritos and Pepsi-Cola, plans to completely eliminate nearly 20% of its products in the U.S. by early next year. PepsiCo is the latest company to respond to poor consumer sentiment and affordability concerns among Americans. Facing weakened consumer demand like PepsiCo, Target recently announced price reductions on 3,000 food, beverage and essential items. Target reported a 2.7% drop in sales in its latest quarter amid a 1.5% slide in revenue.
The company did not specify which remaining products would have reduced prices, saying it plans a “targeted approach” to achieve “sharper everyday value.” PepsiCo’s North American supply chain will also be reviewed as part of the initiative, according to the statement, which said the changes aim to “accelerate organic revenue growth, deliver record productivity savings and improve core operating margin – starting in 2026.” The company said that in its push to reduce operating costs, it has closed three manufacturing plants and shuttered “several manufacturing lines this year.”
Read more at Forbes
Pentagon Issues $1.14B for F-35 Supplies
Lockheed Martin has picked up a $1.14-billion modification to a previously assigned contract for purchasing long-lead materials for a total of 198 F-35 aircraft. The Pentagon announcement of the award indicated it anticipates production of 65 jets for Lot 20 and 133 for Lot 21. However, no firm contract for those aircraft has been settled. The current award is intended to avoid program delays due to sourcing of materials, components, and systems once the Pentagon and Lockheed arrive at an agreement. Once production is agreed, the work will be performed at multiple Lockheed locations in the U.S. and one in England. The project is scheduled for completion in December 2030.
The F-35 is a series of fighter jets deployed for ground attack and combat, and available in three variants – for the U.S. Air Force, U.S. Marine Corps, U.S. Navy, and for the defense forces of more than a dozen other nations. Lots 20 and 21 will incorporate the various hardware and software updates planned as part of the F-35 Block 4 update – which will introduce more than 80 improved capabilities meant to keep the F-35 competitive against emerging threats, including improved sensors, sensor fusion, and expanded weapon capabilities.
Read more at American Machinist
Pentagon Eyes Near-Term AI Adoption
The Trump administration is gearing up to launch an ambitious new plan to spur the military’s near-term adoption of artificial intelligence assets by supplying commercial options directly to users on the ground across three categories that reflect real-world operational needs, according to the Pentagon’s chief technology officer. Pentagon CTO and R&E leader Emil Michael shared new details about the DOD’s latest pursuits to reform and accelerate AI integration for in-office functions and modern warfare, during a roundtable with reporters on Monday hosted by the Defense Writers Group.
Noting that the CDAO’s approach and mission has shape-shifted a number of times since its early days, Pentagon CTO and R&E leader Emil Michael said the “new regime” will be primarily focused on building stronger relationships with major AI companies to quickly deliver models and tools that are tailored for Pentagon-specific use cases. “Now you have four giant companies: Anthropic, xAI, OpenAI and Google, right? So, you have four investing hundreds of billions of dollars in infrastructure, in research and development, data centers, power cooling chips — you name it. So the explosion of capabilities has been enormous, and we’re just catching up to that.”
Read more at Defense Scoop
Discrimination Lawsuit Ends with a $11.5 Million Verdict Against SHRM
A Colorado jury on Friday returned a verdict in favor of the plaintiff in SHRM’s race discrimination and retaliation trial, awarding the plaintiff compensatory damages of $1.5 million and punitive damages of $10 million. The jury verdict came in Friday afternoon, capping off a week-long trial that dug into allegations from a former instructional designer that the HR organization retaliated against her and set her up to be fired after she complained that her supervisor favored direct reports who were White over those who were not. The unfavorable verdict is the latest challenge in what has been a rocky year for SHRM.
SHRM was adamant the jury had reached the wrong conclusion. “This claim has no merit. None. Today’s decision does not reflect the facts, the law, or the truth of how SHRM operates,” SHRM said. “We have acted with integrity, transparency, and in full alignment with our values and obligations. We remain steadfast in our mission, undeterred in our focus, and resolute in our commitment to stand up for what is right.” Ashley Herd, founder and CEO of Manager Method and co-host of the “HR Besties” podcast, said in a recent LinkedIn post that all HR leaders should be paying attention to the case. “It’s a reminder of why processes and conversations matter — and how easy it can be for ‘best practices’ to not actually be followed in real life,” she wrote.
Read more at HR Dive
TSMC Says It Is Accelerating An Advanced Packaging Facility In Arizona
One of the caveats of TSMC's manufacturing in the U.S. is that all wafers processed at Fab 21 in Arizona are shipped back to Taiwan for dicing, testing, and packaging, which is why processors fabbed in Arizona are not 100% U.S.-made. However, TSMC is reportedly repurposing land designated initially for one of its Fab 21 modules for its advanced packaging facility, thus accelerating its packaging capability in the U.S. and making 'all American TSMC chips' a reality before 2030.
Based on the latest expansion plan for the Arizona site announced in March, TSMC plans to build six Fab 21 modules, two advanced packaging facilities, and an R&D center to work on the foundry's existing technologies and tailor them for specific customers. Liberty Times claims that TSMC now intends to build its advanced packaging facility on the place originally intended for the Fab 21 phase 6. If construction proceeds according to the alleged plan, tool move-in could begin before the end of 2027, enabling the plant to enter a risk production phase shortly thereafter.
Read more at Tom’s Hardware
Pfizer Adds To Obesity Bet With Up To $2.1 Billion Deal To Develop Chinese Company’s Pill
Pfizer on Tuesday said it has struck an up to $2.1 billion licensing deal with YaoPharma to develop and commercialize its obesity pill, furthering the pharmaceutical company’s push into the weight loss space. Pfizer will pay YaoPharma, a subsidiary of Chinese drugmaker Shanghai Fosun Pharmaceutical, an upfront payment of $150 million. YaoPharma could also receive up to $1.94 billion in milestone payments, along with tiered royalties on sales if the drug is approved.
YaoPharma’s drug works by targeting the same gut hormone, GLP-1, as Novo Nordisk ’s blockbuster weight loss injection Wegovy. But the pill is still in early-stage development, which means it will take several years before it reaches patients. The deal will help Pfizer beef up and diversify its obesity drug pipeline after a string of setbacks, including its decisions to scrap two different pills over the last two years. The drugmaker boosted its prospects in the competitive space with its up to $10 billion acquisition of the obesity biotech Metsera last month, following a fierce bidding war with Novo Nordisk.
Read more at CNBC
Microsoft Investing $17.5 Billion In India For AI And Cloud Infrastructure
Microsoft on Tuesday announced its biggest-ever Asia investment, amounting to $17.5 billion, in India over the next four years to advance the country’s cloud and artificial intelligence infrastructure. CEO Satya Nadella revealed this in an X post after meeting with Indian Prime Minister Narendra Modi in New Delhi. Nadella said that Microsoft was committing the investments to help India build the “infrastructure, skills and sovereign capabilities” needed for its AI future.
The announcement underscores the growing global competition among major technology companies to expand in India, which has become one of the world’s fastest-growing digital markets. In October, Google said it will invest $15 billion in India over the next five years to establish its first AI hub in the country. Located in the southern city of Visakhapatnam, the hub will be one of Google’s largest globally.
Read more at The Hill
Amazon Leads $81 Million Financing for Battery Startup Blue Current
Amazon.com has led an $81 million funding round for battery startup Blue Current, a deal that comes as the e-commerce giant is expanding its fleet of electric delivery vans. Blue Current is making battery cells at a facility in Hayward, Calif., and said its batteries could be on the market by 2030. Founded in 2014, Blue Current says its silicon solid-state batteries can power a variety of vehicles and offer them longer range and faster charging rates than existing electric-vehicle batteries.
Solid-state batteries are prized by automakers looking for safer alternatives to combustible lithium-ion batteries, as well as for their potential to store greater amounts of energy and charge faster than their lithium-ion rivals. But costly manufacturing and other hurdles have kept them from becoming commercially viable. Global private battery companies are expected to have raised $19.6 billion by the end of this year, 34% less than they raised in 2024, according to a report by climate-tech analytics firm Net Zero Insights.
Read more at The WSJ
|